ICICU Medical ICUI · NASDAQ
$172.62 +6.67% (+$10.79)
- Market cap
- $4.32B
- Enterprise value
- $5.29B
- P/E
- 143.5x
- Forward P/E
- 19.8x
- PEG
- -
- P/S
- 2.0x
- P/FCF
- 28.2x
- EV/EBITDA
- 17.8x
- ROIC
- -21.7%
- Gross margin
- 37.6%
- Net margin
- 1.4%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 3.3x
- Beta
- 0.76
- Free float
- 98.2%
About the company
ICU Medical, Inc. is a U.S.-based healthcare company that specializes in the manufacturing and development of devices and systems for intravenous therapy, anesthesia, and intensive care. The company is particularly known for its infusion pumps, closed systems for intravenous drug administration, and monitoring technologies that ensure patient safety in hospital and clinical settings. ICU Medical focuses on providing advanced solutions to enhance patient care and optimize healthcare processes.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Vivek Jain
Employees
13,000
Headquarters
San Clemente
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: It beat profit estimates 8 times in the last 8 quarters.
- What to watch: Revenue fell by 0.7% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: Out of every 100 USD of revenue, only 1.4 USD is left as net profit.
Financial health
Can it carry its debt?
- What to watch: Operating profit does not even cover the interest on its debt.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number